title: Effective inhibition of human immunodeficiency virus 1 replication by engineered RNase P ribozyme.
abstract: Using an in vitro selection procedure, we have previously isolated RNase P ribozyme variants that efficiently cleave an mRNA sequence in vitro. In this study, a variant was used to target the HIV RNA sequence in the tat region. The variant cleaved the tat RNA sequence in vitro about 20 times more efficiently than the wild type ribozyme. Our results provide the first direct evidence that combined mutations at nucleotide 83 and 340 of RNase P catalytic RNA from Escherichia coli (G(83) -> U(83) and G(340) -> A(340)) increase the overall efficiency of the ribozyme in cleaving an HIV RNA sequence. Moreover, the variant is more effective in reducing HIV-1 p24 expression and intracellular viral RNA level in cells than the wild type ribozyme. A reduction of about 90% in viral RNA level and a reduction of 150 fold in viral growth were observed in cells that expressed the variant, while a reduction of less than 10% was observed in cells that either did not express the ribozyme or produced a catalytically inactive ribozyme mutant. Thus, engineered ribozyme variants are effective in inhibiting HIV infection. These results also demonstrate the potential of engineering RNase P ribozymes for anti-HIV application.
authors.affiliation: State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei, China.
authors.forename: Wenbo
authors.initials: W
authors.lastname: Zeng
authors.forename: Yuan-Chuan
authors.initials: YC
authors.lastname: Chen
authors.forename: Yong
authors.initials: Y
authors.lastname: Bai
authors.forename: Phong
authors.initials: P
authors.lastname: Trang
authors.forename: Gia-Phong
authors.initials: GP
authors.lastname: Vu
authors.forename: Sangwei
authors.initials: S
authors.lastname: Lu
authors.forename: Jianguo
authors.initials: J
authors.lastname: Wu
authors.forename: Fenyong
authors.initials: F
authors.lastname: Liu
mesh_terms: D015152:Blotting, Northern; D002478:Cells, Cultured; D015967:Gene Expression Regulation, Viral; D015658:HIV Infections / Q000235:genetics / Q000517:prevention & control* / Q000821:virology; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D009690:Nucleic Acid Conformation; D016337:RNA, Catalytic / Q000494:pharmacology*; D012367:RNA, Viral; D043262:Ribonuclease P / Q000235:genetics* / Q000378:metabolism; D014779:Virus Replication / Q000235:genetics*
chemical_list: D016337:RNA, Catalytic; D012367:RNA, Viral; D043262:Ribonuclease P